Abstract:Study question: What are the general public's reasons for being in favour of or against the use of genome modification for five potential applications? Summary answer: Overall, 43 reasons for being in favour, 45 reasons for being against as well as 26 conditional reasons for the use of genome modification were identified. What is known already: Various applications of somatic genome modification are progressing towards clinical introduction and several recent studies have reported on germline genome modification. This has incited a debate on ethical and legal implications and acceptability. There is a growing plea to involve the general public earlier on in the developmental process of science and (bio)technology including genome modification. Study design size duration: In April 2016, a cross-sectional survey was launched online among the Dutch general public. A documentary on genome modification on public television and calls in social media invited viewers and non-viewers, respectively, to participate. Participants/materials setting methods: The questionnaire introduced five potential future applications of genome modification: modified wheat for individuals with gluten intolerance; somatic modification for individuals with neuromuscular diseases; germline modification to prevent passing on a neuromuscular disease; germline modification to introduce resistance to HIV; and germline modification to increase intelligence. Participants were asked to indicate whether and why they would make use of genome modification in these scenarios. The reasons mentioned were analysed through content analysis by two researchers independently. The proportion of respondents that was willing to modify was described per scenario and associations with respondent characteristics were analysed. Main results and the role of chance: The survey was completed by 1013 participants. Forty-three reasons for being in favour, 45 reasons for being against as well as 26 conditional reasons for the use of genome modification were identified. These could be categorized into 14 domains: safety of the individuals concerned; effectiveness; quality of life of the individuals concerned; existence of a clinical need or an alternative; biodiversity and ecosystems; animal homo sapiens (i.e. relating to effects on humans as a species); human life and dignity; trust in regulation; justice; costs; slippery slope; argument of nature; parental rights and duties; and (reproductive) autonomy. Participants' willingness to use genome modification was dependent on the application: most participants would eat modified wheat if gluten intolerant (74%), would use genome modification to cure his/her own neuromuscular disease (85%) and would apply germline modification to prevent passing on this neuromuscular disease (66%). A minority would apply germline modification to introduce resistance to HIV (30%) or increase intelligence (16%). Being young (odds ratio (OR) = 0.98 per year increase), being male (OR = 2.38), and having watched the documentary (OR = 1.82) were associated with being willing to apply genome modification in more scenarios. Limitations reasons for caution: Inquiring for reasons through open questions in a survey allowed for a larger sample size and intuitive responses but resulted in less depth than traditional face-to-face interviews. As the survey was disseminated through social media, the sample is not representative of the overall Dutch population, and hence the quantitative results should not be interpreted as such. Wider implications of the findings: Further public consultation and a more in-depth ethical and societal debate on principles and conditions for responsible use of (germline) genome modification is required prior to future clinical introduction. Study funding/competing interests: Funded by the University of Amsterdam and University Medical Centre Utrecht. No conflict of interest. Trial registration number: Not applicable.

Genetic screening: a comparative analysis of three recent reports

Genetic Screening—Emerging Issues

Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

Ethical issues raised by new genomic technologies: the case study of newborn genome screening

Genetic Screening: Marvel or Menace?

Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews

Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews

Population genomic screening: Ethical considerations to guide age at implementation

Should genetic findings from genome research be reported back to the participants?

Preferences of parents from diverse backgrounds on genomic screening of apparently healthy newborns

Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature

Exploring the benefits, harms and costs of genomic newborn screening for rare diseases

Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities

Reasons for being in favour of or against genome modification: a survey of the Dutch general public

Genetic testing in psychiatry, the perceptions of healthcare workers and patients: a mini review

Comparative analysis of gene and disease selection in genomic newborn screening studies

The Modernisation of Newborn Screening as a Pan-European Challenge – An International Delphi Study

Preserving women’s reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany

Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation

Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France

Ethical considerations in prenatal genomic testing